South Korea’s two leading drugmakers, Celltrion Inc. and Samsung Bioepis Co., have achieved a significant milestone in the European biosimilar market, capturing over 50% market share in the six ...

Of the 50 different drugs approved by the U.S. Food and Drug Administration (FDA) in 2024, 18 of these agents were biosimilars, eight of which target reference products with no previous biosimilar ...

House Republicans are considering nixing a Medicaid drug-pricing plan floated by President Trump and fiercely opposed by the pharmaceutical industry as the party pushes to strike a massive tax ...

The Indian government is refining biosimilar drug regulations, aligning with global standards to ensure stringent quality in research and manufacturing. These revised 'Guidelines on Similar Biologics' ...

While biosimilar drugs promise greater affordability and accessibility for millions with chronic diseases, can this momentum of bringing biosimilars to the market persist despite the rising costs ...

Heroin remains the most seized drug. Areas under the Sector-39 police station have emerged as the hotbed of narcotics activity in Chandigarh, clocking the highest number of NDPS Act cases—85 ...

Merck’s Keytruda is the world’s top-selling drug, bringing in nearly $30 billion ... open the way for less costly versions known as biosimilars. Merck’s efforts to change the blockbuster ...

diabetes drugs hold top spot; biosimilar adoption up more than 27 per cent. "Private sector drug plans protect and increase access to pharmaceutical care, but they are in constant need of expert ...

Sandoz has signed a global collaboration agreement with Shanghai Henlius Biotech to commercialize a biosimilar of oncology therapy, ipilimumab (Bristol-Myers Squibb’s Yervoy). The agreement is ...

Biosimilars are near-identical copies of complex biologic drugs whose patents have expired. Saynor said some form of U.S. price reform is inevitable, pointing to President Donald Trump’s stalled ...